GUANIDINOACETIC ACID(GAA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE(CKD) AND DIABETES MELLITUS(DM)
نویسندگان
چکیده
منابع مشابه
the past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Preventing amputations in patients with diabetes and chronic kidney disease.
Amputations of the lower extremities add significantly to the morbidity and mortality of patients with diabetes and chronic kidney disease (CKD). Dialysis nurses are in an optimal position to make a positive impact on the high rate of amputation among patients with diabetes receiving dialysis through early detection and intervention. Routine foot screening and education can assist in identifyin...
متن کاملSupplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome.
A variety of dietary interventions has been used in the management of chronic fatigue syndrome (CFS), yet no therapeutic modality has demonstrated conclusive positive results in terms of effectiveness. The main aim of this study was to evaluate the effects of orally administered guanidinoacetic acid (GAA) on multidimensional fatigue inventory (MFI), musculoskeletal soreness, health-related qual...
متن کاملManagement of diabetes mellitus in patients with chronic kidney disease
Glycemic control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications available but only a fraction of them can be used safely in chronic kidney disease and many of them need an adjustment in dosing. The ideal target hemoglobin A1c is approximately 7 % but this target is adjusted based on the needs of the patient. Diabetes con...
متن کاملManaging diabetes in hospitalized patients with chronic kidney disease.
Because few randomized trials have been done, little is known about appropriate glycemic control in hospitalized patients with chronic kidney disease (CKD) and diabetes mellitus. These patients are at high risk of hypoglycemia. It is prudent to monitor glucose closely, set less-stringent blood sugar goals, avoid oral antidiabetic agents, and possibly reduce insulin dosage.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney Research and Clinical Practice
سال: 2012
ISSN: 2211-9132
DOI: 10.1016/j.krcp.2012.04.581